UBS Group’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
Other funds holding HOLX
VCM
HI
VPM
PCM
UBS Group's HOLX Position: Q1 2026 in Review
UBS Group increased its Hologic (HOLX) stake by 62% in Q1 2026, buying an estimated $147M and bringing the position to 5,089,745 shares worth $385M. The position accounts for 0.06% of the portfolio, ranked #339.
UBS Group first reported a position in HOLX in Q4 2014 and has held it in 46 quarters since. 704 funds tracked by Wall St. Rank hold HOLX as of Q1 2026.
- UBS Group held 5,089,745 shares of Hologic worth $385M as of Q1 2026.
- UBS Group bought 1,950,084 Hologic shares in Q1 2026, an estimated $147M.
- Hologic made up 0.06% of UBS Group's portfolio in Q1 2026, its #339 holding.
- UBS Group first reported a position in Hologic in Q4 2014 and has held it in 46 quarters since.
- 704 funds tracked by Wall St. Rank held Hologic as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.